Skip navigationU.S. Food and Drug Administration Center for Drug Evaluation and Research

CDER - Center for Drug Evaluation and Research Logo

Office of Generic Drugs

Reference Listed Drug Labeling and Efficacy Supplements Approved in November 2002
Click on appropriate hyperlink below to view available source document in PDF format

Approval

Date

Product Name

Source Documents

Active Ingredient(s)/Dosage Form

Document ID No.
Nov 1

ALLEGRA-D

letter   

fexofenadine HCl/pseudoephedrine HCl ER tablets.

20-786 SLR 012
Nov 1

FLOVENT DISKUS

letter    

fluticasone dipropionate inhalation powder

20-833 SLR 002
Nov 1

FRAGMIN

letter    

dalteparin Na injection

20-287 SLR 027
Nov 1

TRINALIN

letter    

azatadine maleate/pseudoephedrine sulfate tablets

18-506 SLR 024
Nov 1

VASERETIC

letter     

enalapril maleate/hydrochlorothiazide tablets

19-221 SLR 027
Nov 1

VASOTEC IV

letter    

enalaprilat injection

19-309 SLR 025
Nov 4

OPTIMINE

letter   

azatadine maleate tablets.

17-601 SLR 020
Nov 4

PHOSLO

letter label

calcium acetate tablets

19-976 SLR 005
Nov 5

CORTROSYN

letter label

cosyntropin for injection

16-750 SLR 018
Nov 5

ETOPOPHOS

letter label

etoposide phosphate for injection

20-457 SLR 006
Nov 5

NAVELBINE

letter label

vinorelbine tartrate injection

20-388 SE8 014
Nov 5

VEPESID

letter label

etoposide injection

19-557 SLR 028
Nov 5

VEPESID

letter label

etoposide injection

18-768 SLR 045
Nov 7

HYZAAR

letter label

losartan potassium/hydrochlorothiazide tablets

20-387 SLR 024
Nov 8

ACIPHEX

letter label

rabeprazole Na delayed-release tablets

20-973 SE8 013
Nov 8

PLATINOL

letter label

cisplatin injection

18-057 SLR 076
Nov 8

PRINZIDE

letter label

lisinopril/hydrochlorothiazide tablets

19-778 SLR 032
Nov 13

CEREZYME

  label

imiglucerase for injection

20-367 SLR 055
Nov 13

REBETRON

letter label

rebetol/Intron A combination therapy

20-903 SLR 025
Nov 14

DORAL

letter label

quazepam tablets

18-708 SLR 014
Nov 14

KETALAR

letter label

ketamine HCl for injection

16-812 SLR 032
Nov 14

ORAP

letter label

pimozide tablets

17-473 SLR 038
Nov 14

REMERON SOLTAB

letter label

mirtazapine orally disintegrating tablets

21-208 SLR 006
Nov 19

CELEXA

letter label

citalopram HBr tablets

21-046 SLR 003
Nov 19

CELEXA

letter label

citalopram HBr oral solution

20-822 SLR 019
Nov 19

FELBATOL

letter label

felbamate tablets

20-189 SLR 018
Nov 19

FRAGMIN

letter label

dalteparin Na injection

20-287 SLR 029
Nov 19

RISPERDAL

letter label

risperidone oral solution

20-588 SLR 015
Nov 19

RISPERDAL

letter label

risperidone tablets

20-272 SLR 024
Nov 21

CANCIDAS

letter label

caspofungin acetate injection

21-227 SLR 005
Nov 22

PREVPAC

letter label

ansoprazole/amoxicillin/clarithromycin

50-757 SLR 006
Nov 25

MIOSTAT

letter label

carbachol intraocular solution

16-968 SLR 020
Nov 25

VISUDYNE

letter label

verteporfin injection

21-119 SLR 005
Nov 26

PAH

letter label

aminohippurate Na injection

05-619 SLR 018
Nov 26

STARLIX

letter label

nateglinide tablets

21-204 SLR 005
Nov 26

TOPAMAX

letter label

topiramate tablets

20-505 SLR 016
Nov 26

TOPAMAX SPRINKLE

letter label

topiramate capsules

20-844 SLR 013
Nov 26

VOLTAREN

letter label

diclofenac Na tablets

19-201 SLR 018
Nov 27

CLARITIN

letter label

loratadine syrup

20-641 SE6 009
Nov 27

CLARITIN

letter label

loratadine tabelts

19-658 SE6 018
Nov 27

CLARITIN REDITABS

letter label

loratadine orally disintigrating tablets

20-704 SE6 008
Nov 27

CLARITIN-D 12

letter label

loratadine/pseudoephedrine sulfate ER tablets

19-670 SE6 018
Nov 27

CLARITIN-D 24

letter label

loratadine/pseudoephedrine sulfate ER tablets

20-470 SE6 016
Nov 27

KALETRA

letter label

lopinavir/ritonavir oral solution

21-251 SE7 005
Nov 27

KALETRA

letter label

lopinavir/ritonavir capsules

21-226 SE7 006
Nov 27

PREMARIN

letter label

conjugated estrogens tablets

04-782 SLR 128
Nov 27

PREMPRO

letter label

conjugated estrogens /medroxyprogeterone acetate tablets

20-527 SLR 029
Nov 27

TAXOTERE

  label

docetaxel injection

20-449 SE1 018
Nov 27

ZANAFLEX

letter label

tizanidine tablets

20-397 SLR 014

totop.gif (1525 bytes) Back to Top

Back Labeling Review Branch Page

FDA/Center for Drug Evaluation and Research
Last Updated: January 18, 2006
Originator: OTCOM/DLIS
HTML by JFG